| http://www.w3.org/ns/prov#value | - When making the announcement, Mr. Needleman cited Aptuit???s substantial range of pharmacology expertise and capabilities to support the development of biologicals for the translational disease relevant models, including oncology, inflammatory diseases, metabolic disorders such as diabetes, psychiatry and neurology, neurodegeneration, pain and infections.
|
